BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Gena Wang

Barclays · Equity Research Analyst

Analyst rating accuracy & track record

Gena Wang does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
SGMOSangamo Therapeutics Inc
Buy$5.00May 2025−82.1%Miss
CLLSCellectis SA
Buy$4.00May 2025+172.4%Hit
FDMT4D Molecular Therapeutics Inc
Buy$38.00May 2025+217.9%Miss
VIRVir Biotechnology Inc
Buy$31.00Feb 2025+10.1%Miss
SGMOSangamo Therapeutics Inc
Buy$9.00Nov 2024−87.3%Miss
CLLSCellectis SA
Buy$5.00Nov 2024+84.0%Hit
VIRVir Biotechnology Inc
Buy$26.00Nov 2024−45.4%Miss
MRNAModerna Inc
Buy$125.00Sep 2024−55.0%Miss
VIRVir Biotechnology Inc
Buy$28.00Aug 2024−33.2%Miss
MGTXMeiraGTx Holdings PLC
Buy$18.00May 2022−31.0%Miss
CLLSCellectis SA
Buy$7.00May 2022−47.5%Miss
SLDBSolid Biosciences LLC
Buy$8.00May 2021−93.5%Miss
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30